Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still's Disease with Liver Failure with No Response to Tocilizumab Therapy

A 21-year-old woman with refractory systemic flare of adult-onset Still's disease with liver failure despite high-dose corticosteroids, cyclosporine, tacrolimus, and tocilizumab, was successfully treated with additional use of etanercept. Etanercept at a dose of 50 mg weekly was partially effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Naniwa, Taio, Tamechika, Shinya, Iwagaitsu, Shiho, Maeda, Shinji, Togawa, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877607/
https://www.ncbi.nlm.nih.gov/pubmed/24455384
http://dx.doi.org/10.1155/2013/923497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877607/
https://www.ncbi.nlm.nih.gov/pubmed/24455384
http://dx.doi.org/10.1155/2013/923497

Ejemplares similares